Compare SOPH & USNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SOPH | USNA |
|---|---|---|
| Founded | 2011 | 1992 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 330.4M | 371.5M |
| IPO Year | 2021 | 1996 |
| Metric | SOPH | USNA |
|---|---|---|
| Price | $4.96 | $19.58 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 1 |
| Target Price | $7.00 | ★ $36.00 |
| AVG Volume (30 Days) | 56.8K | ★ 137.8K |
| Earning Date | 11-04-2025 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.90 |
| Revenue | $73,297,000.00 | ★ $912,670,000.00 |
| Revenue This Year | $18.32 | $9.80 |
| Revenue Next Year | $15.61 | N/A |
| P/E Ratio | ★ N/A | $21.68 |
| Revenue Growth | ★ 13.66 | 5.88 |
| 52 Week Low | $2.58 | $18.48 |
| 52 Week High | $5.30 | $38.32 |
| Indicator | SOPH | USNA |
|---|---|---|
| Relative Strength Index (RSI) | 59.24 | 46.10 |
| Support Level | $4.52 | $18.94 |
| Resistance Level | $4.82 | $19.98 |
| Average True Range (ATR) | 0.19 | 0.50 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 87.27 | 38.30 |
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.